Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Ward

Showing results (451-460 of 481) with videos related to

Pageof 49
Sort By:
The Journal of Infectious Diseases|June 4, 2018
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman PrimatesKristen E Pascal, Drew Dudgeon, John C Trefry, et al.
Immunity|March 25, 2025
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutininsJenna J Guthmiller, Linda Yu-Ling Lan, Lei Li, et al.
Cell Reports|April 17, 2026
Structural and immunogenetic signatures guide CD4-mimetic HIV vaccine developmentDaniel L V Bader, Claudia T Flynn, Oleksandr Kalyuzhniy, et al.
Cell Reports. Medicine|April 12, 2023
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertionsTom G Caniels, Max Medina-Ramírez, Jinsong Zhang, et al.
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Germline-targeting SOSIP trimer immunization elicits precursor CD4 binding-site targeting broadly neutralizing antibodies in infant macaquesAshley N Nelson, Xiaoying Shen, Sravani Vekatayogi, et al.
Immunity|June 22, 2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized ApproachesMatthias Pauthner, Colin Havenar-Daughton, Devin Sok, et al.
Cell|September 24, 2020
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2Thomas Mandel Clausen, Daniel R Sandoval, Charlotte B Spliid, et al.
Science Immunology|August 30, 2024
Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaquesAshley N Nelson, Xiaoying Shen, Sravani Vekatayogi, et al.
Nature Communications|June 3, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody responseKenta Matsuda, Mitra Harrison, Eleanor Wettstein, et al.
Pageof 49

Showing results (451-460 of 481) with videos related to

Sort By:
Pageof 49
The Journal of Infectious Diseases|June 4, 2018
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman PrimatesKristen E Pascal, Drew Dudgeon, John C Trefry, et al.
Immunity|March 25, 2025
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutininsJenna J Guthmiller, Linda Yu-Ling Lan, Lei Li, et al.
Cell Reports|April 17, 2026
Structural and immunogenetic signatures guide CD4-mimetic HIV vaccine developmentDaniel L V Bader, Claudia T Flynn, Oleksandr Kalyuzhniy, et al.
Cell Reports. Medicine|April 12, 2023
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertionsTom G Caniels, Max Medina-Ramírez, Jinsong Zhang, et al.
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Germline-targeting SOSIP trimer immunization elicits precursor CD4 binding-site targeting broadly neutralizing antibodies in infant macaquesAshley N Nelson, Xiaoying Shen, Sravani Vekatayogi, et al.
Immunity|June 22, 2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized ApproachesMatthias Pauthner, Colin Havenar-Daughton, Devin Sok, et al.
Cell|September 24, 2020
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2Thomas Mandel Clausen, Daniel R Sandoval, Charlotte B Spliid, et al.
Science Immunology|August 30, 2024
Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaquesAshley N Nelson, Xiaoying Shen, Sravani Vekatayogi, et al.
Nature Communications|June 3, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody responseKenta Matsuda, Mitra Harrison, Eleanor Wettstein, et al.
Pageof 49